BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18644731)

  • 1. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
    Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
    Gong W; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of nuclease-resistant siRNAs possessing universal overhangs.
    Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y
    Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference in mammalian cells by siRNAs modified with morpholino nucleoside analogues.
    Zhang N; Tan C; Cai P; Zhang P; Zhao Y; Jiang Y
    Bioorg Med Chem; 2009 Mar; 17(6):2441-6. PubMed ID: 19233658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of oligonucleotides carrying amino lipid groups at the 3'-end for RNA interference studies.
    Grijalvo S; Ocampo SM; Perales JC; Eritja R
    J Org Chem; 2010 Oct; 75(20):6806-13. PubMed ID: 20863084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
    Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
    FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.
    Myers JW; Jones JT; Meyer T; Ferrell JE
    Nat Biotechnol; 2003 Mar; 21(3):324-8. PubMed ID: 12592410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity.
    Li ZS; Qiao RP; Du Q; Yang ZJ; Zhang LR; Zhang PZ; Liang ZC; Zhang LH
    Bioconjug Chem; 2007; 18(4):1017-24. PubMed ID: 17539595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
    Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
    Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Mol Pharm; 2012 May; 9(5):1374-83. PubMed ID: 22494497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of nuclease-resistant siRNAs possessing benzene-phosphate backbones in their 3'-overhang regions.
    Ueno Y; Inoue T; Yoshida M; Yoshikawa K; Shibata A; Kitamura Y; Kitade Y
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5194-6. PubMed ID: 18783944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing and utilization of siRNAs targeting RNA binding proteins.
    Kim DH; Behlke M; Rossi JJ
    Methods Mol Biol; 2008; 488():367-81. PubMed ID: 18982303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of thiophosphate substitutions on native siRNA gene silencing.
    Li ZY; Mao H; Kallick DA; Gorenstein DG
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1026-30. PubMed ID: 15752758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
    Kubo T; Yanagihara K; Sato Y; Nishimura Y; Kondo S; Seyama T
    Bioconjug Chem; 2013 Dec; 24(12):2045-57. PubMed ID: 24274056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
    Czauderna F; Fechtner M; Dames S; Aygün H; Klippel A; Pronk GJ; Giese K; Kaufmann J
    Nucleic Acids Res; 2003 Jun; 31(11):2705-16. PubMed ID: 12771196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.